Cargando…

B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies

Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes severe disease in immunosuppressed patients and infected newborns. Efforts are underway to prepare effective subunit vaccines and therapies including antiviral antibodies. However, current vaccine efforts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pötzsch, Sonja, Spindler, Nadja, Wiegers, Anna-Katharina, Fisch, Tanja, Rücker, Pia, Sticht, Heinrich, Grieb, Nina, Baroti, Tina, Weisel, Florian, Stamminger, Thomas, Martin-Parras, Luis, Mach, Michael, Winkler, Thomas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154849/ https://www.ncbi.nlm.nih.gov/pubmed/21852946 http://dx.doi.org/10.1371/journal.ppat.1002172

Ejemplares similares

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
por: Bootz, Anna, et al.
Publicado: (2017)

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
por: Kropff, Barbara, et al.
Publicado: (2012)

Crystal Structure of the Human Cytomegalovirus Glycoprotein B
por: Burke, Heidi G., et al.
Publicado: (2015)

Correction: Crystal Structure of the Human Cytomegalovirus Glycoprotein B
por: Burke, Heidi G., et al.
Publicado: (2015)

Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins
por: Steingruber, Mirjam, et al.
Publicado: (2016)

Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection
por: Valencia, Sarah M., et al.
Publicado: (2023)

The Role of the Pre-B Cell Receptor in B Cell Development, Repertoire Selection, and Tolerance
por: Winkler, Thomas H., et al.
Publicado: (2018)

Cytomegalovirus Glycoprotein B Genotype in Patients with Anterior Segment Infection
por: Huang, Chu-Yen, et al.
Publicado: (2023)

Crystal Structure of Cytomegalovirus IE1 Protein Reveals Targeting of TRIM Family Member PML via Coiled-Coil Interactions
por: Scherer, Myriam, et al.
Publicado: (2014)

The Incidence of Cytomegalovirus Glycoprotein B Genotypes in Kidney Transplant Recipients in Iran
por: Soleimani, A. R., et al.
Publicado: (2018)

Polymorphisms of the cytomegalovirus glycoprotein B genotype in patients with Posner-Schlossman syndrome
por: Zhai, Ruyi, et al.
Publicado: (2022)

Intrinsic Immune Mechanisms Restricting Human Cytomegalovirus Replication
por: Schilling, Eva-Maria, et al.
Publicado: (2021)

1113 Safety and Efficacy of a Cytomegalovirus Glycoprotein B (gB) Vaccine in Adolescent Girls
por: Bernstein, David I., et al.
Publicado: (2014)

Prefusion structure of human cytomegalovirus glycoprotein B and structural basis for membrane fusion
por: Liu, Yuhang, et al.
Publicado: (2021)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
por: Kalser, Julia, et al.
Publicado: (2017)

The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain
por: Steingruber, Mirjam, et al.
Publicado: (2015)

Control of Murine Cytomegalovirus Infection by γδ T Cells
por: Sell, Sabrina, et al.
Publicado: (2015)

Cytomegalovirus Genotype Distribution among Postnatally Infected Infants: Association of Glycoprotein B, Glycoprotein N and Glycoprotein H Types with CMV-Associated Thrombocytopenia
por: Hu, Hongbo, et al.
Publicado: (2020)

Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy()
por: Emery, Vincent C., et al.
Publicado: (2012)

Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
por: Fan, Jun, et al.
Publicado: (2012)

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
por: Siddiqui, Saima, et al.
Publicado: (2020)

A Virus Genetic System to Analyze the Fusogenicity of Human Cytomegalovirus Glycoprotein B Variants
por: Zhou, Xuan, et al.
Publicado: (2023)

Highly Conserved Interaction Profiles between Clinically Relevant Mutants of the Cytomegalovirus CDK-like Kinase pUL97 and Human Cyclins: Functional Significance of Cyclin H
por: Schütz, Martin, et al.
Publicado: (2022)

Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells
por: Seitz, Sven, et al.
Publicado: (2022)

Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine
por: Arav-Boger, Ravit, et al.
Publicado: (2012)

Determination of Cytomegalovirus Prevalence and Glycoprotein B Genotypes Among Ulcerative Colitis Patients in Ahvaz, Iran
por: Taherkhani, Reza, et al.
Publicado: (2015)

Mixed infections with distinct cytomegalovirus glycoprotein B genotypes in Polish pregnant women, fetuses, and newborns
por: Rycel, M., et al.
Publicado: (2014)

Determining immunoglobulin-specific B cell receptor repertoire of murine splenocytes by next-generation sequencing
por: Werner, Anja, et al.
Publicado: (2022)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

RNA-binding of the human cytomegalovirus transactivator protein UL69, mediated by arginine-rich motifs, is not required for nuclear export of unspliced RNA
por: Toth, Zsolt, et al.
Publicado: (2006)

Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
por: Jung, Susanne, et al.
Publicado: (2019)

Molecular Detection and Glycoprotein B (UL55) Genotyping of Cytomegalovirus among Sudanese Renal Transplant Recipients
por: Ahmed, Hind Haidar, et al.
Publicado: (2022)

Distribution of CMV envelope glycoprotein B, H and N genotypes in infants with congenital cytomegalovirus symptomatic infection
por: Dong, Niuniu, et al.
Publicado: (2023)

Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential
por: Bewarder, Moritz, et al.
Publicado: (2020)

Intracellular Trafficking of the Human Cytomegalovirus-Encoded 7-trans-Membrane Protein Homologs pUS27 and pUL78 during Viral Infection: A Comparative Analysis
por: Niemann, Ina, et al.
Publicado: (2014)

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
por: Li, Fengsheng, et al.
Publicado: (2017)

Cross-Species Analysis of Innate Immune Antagonism by Cytomegalovirus IE1 Protein
por: Rothemund, Franziska, et al.
Publicado: (2022)

Peptides presenting the binding site of human CD4 for the HIV-1 envelope glycoprotein gp120
por: Meier, Julia, et al.
Publicado: (2012)

Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life
por: Attaf, Meriem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7ot36m8ibek96s3clc4e689uv8